Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients

Linda Meade-Tollin, Jesse D. Martinez

Research output: Contribution to journalComment/debatepeer-review

17 Scopus citations
Original languageEnglish (US)
Pages (from-to)288-289
Number of pages2
JournalCancer Biology and Therapy
Issue number2
StatePublished - Feb 2007


  • EphA2
  • Gene expression
  • Ovarian carcinoma
  • p53

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this